⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5694324 | 0.82 | — | — | |
| SCHEMBL8394949 | 0.80 | — | — | |
| SCHEMBL1483256 | 0.79 | — | — | |
| SCHEMBL6434218 | 0.79 | — | — | |
| SCHEMBL22344099 | 0.79 | — | — | |
| SCHEMBL4407965 | 0.75 | TSHR (0.46) | — | |
| SCHEMBL27635 | 0.73 | — | — | |
| SCHEMBL2477687 | 0.73 | — | — | |
| SCHEMBL10604216 | 0.73 | — | — | |
| SCHEMBL1761341 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023166225-A1 | DIGESTIVE ENZYME FORMULATIONS | APET Holding B.V. (NL) | 2023-09-07 | — | — | WO | claimed |
| WO-2023166224-A1 | GASTRORETENTIVE FORMULATIONS CONTAINING PROTEIN OR PEPTIDE | APET Holding B.V. (NL) | 2023-09-07 | — | — | WO | claimed |
| US-20170035677-A1 | ORAL CARE COMPOSITIONS | BRIGHAM YOUNG UNIVERSITY (US) | 2017-02-09 | — | — | US | claimed |
| US-20140363780-A1 | ORAL CARE COMPOSITIONS | BRIGHAM YOUNG UNIVERSITY (US) | 2014-12-11 | — | — | US | claimed |
| EP-0262031-B1 | HIGH POROSITY SILICOCALCAREOUS MASS FOR GAS STORAGE, AND PRODUCTION PROCESS | L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) | 1991-02-20 | — | — | EP | claimed |
| WO-2023166225-A1 | DIGESTIVE ENZYME FORMULATIONS | APET Holding B.V. (NL) | 2023-09-07 | — | — | WO | disclosed |
| WO-2023166224-A1 | GASTRORETENTIVE FORMULATIONS CONTAINING PROTEIN OR PEPTIDE | APET Holding B.V. (NL) | 2023-09-07 | — | — | WO | disclosed |
| CN-111344321-B | Resin composition, cured product, and laminate | DIC株式会社 | 2023-02-24 | — | — | CN | disclosed |
| US-11230633-B2 | Resin composition, cured product and laminate | DIC CORPORATION (JP) | 2022-01-25 | — | — | US | disclosed |
| EP-2941253-B1 | CATIONIC STEROID ANTIMICROBIAL AGENTS FOR USE IN TREATING CANCER | UNIV BRIGHAM YOUNG (US) | 2021-08-11 | — | — | EP | disclosed |
| US-20200368118-A1 | Films and Compositions Comprising the Same | COLGATE-PALMOLIVE COMPANY (US) | 2020-11-26 | — | — | US | disclosed |
| EP-3730526-A1 | RESIN COMPOSITION, CURED PRODUCT AND LAMINATE | DIC Corporation (JP) | 2020-10-28 | — | — | EP | disclosed |
| US-20130266523-A1 | Oral Compositions and Method for Producing Thereof | COLGATE-PALMOLIVE COMPANY | 2013-10-10 | — | — | US | disclosed |
| WO-2013109236-A2 | ORAL CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2013-07-25 | — | — | WO | disclosed |
| WO-2013089734-A1 | AQUEOUS ORAL CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2013-06-20 | — | — | WO | disclosed |
| WO-2012087328-A1 | FILMS AND COMPOSITIONS COMPRISING THE SAME | COLGATE-PALMOLIVE COMPANY (US) | 2012-06-28 | — | — | WO | disclosed |
| WO-2012082450-A2 | ORAL COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2012-06-21 | — | — | WO | disclosed |
| WO-2012082101-A1 | ORAL COMPOSITIONS AND METHOD FOR PRODUCING THEREOF | COLGATE-PALMOLIVE COMPANY (US) | 2012-06-21 | — | — | WO | disclosed |
| WO-2012082098-A1 | ORAL COMPOSITIONS AND METHOD FOR PRODUCING THEREOF | COLGATE-PALMOLIVE COMPANY (US) | 2012-06-21 | — | — | WO | disclosed |
| WO-2012082103-A1 | ORAL COMPOSITIONS AND METHOD FOR PRODUCING THEREOF | COLGATE-PALMOLIVE COMPANY (US) | 2012-06-21 | — | — | WO | disclosed |